What is the primary consideration when deciding antidepressant use in pregnancy?

• A. Always avoid antidepressants during pregnancy.
• B. Treat the mother's psychiatric condition with the same regimen used outside pregnancy, regardless of fetal risk.
• C. Balance fetal risk with maternal psychiatric stability and risk of untreated illness.
• D. Rely solely on antidepressants and disregard psychotherapy.

Answer: (C)

The main idea here is that deciding antidepressant use in pregnancy requires balancing potential fetal risk from the medication with the need to keep the mother anatomically and psychologically stable. Untreated maternal depression poses real dangers to both mother and fetus—risk of relapse, poor prenatal care, substance use, self-harm, and adverse pregnancy outcomes—so maintaining maternal mental health is crucial. At the same time, antidepressants carry some fetal risks, including possible neonatal withdrawal or adaptation symptoms and, in rare cases, other fetal effects, but these risks are typically small and must be weighed against the benefits of continued maternal treatment. The best approach is individualized planning: evaluate the mother’s history and current symptoms, prior responses to treatment, and the specific risks and benefits of available medications; use the lowest effective dose with the safest profile when pharmacotherapy is needed; and combine or pace pharmacologic therapy with psychotherapy and other nonpharmacologic options as appropriate. The goal is to protect the mother’s mental health while minimizing fetal risk.